Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Antimicrobial Agents and Chemotherapy|October 31, 1998
Coresistance to zidovudine and foscarnet is associated with multiple mutations in the human immunodeficiency virus type 1 reverse transcriptaseG Tachedjian, M French, J MillsCurrent Pharmaceutical Design|May 27, 2006
Dimerization of human immunodeficiency virus type 1 reverse transcriptase as an antiviral targetS Srivastava, N Sluis-Cremer, G TachedjianProteins|April 27, 2005
Relationship between enzyme activity and dimeric structure of recombinant HIV-1 reverse transcriptaseG Tachedjian, J Radzio, N Sluis-CremerJournal of Medical Virology|February 1, 1994
Long-term foscarnet therapy not associated with the development of foscarnet-resistant human immunodeficiency virus type 1 in an acquired immunodeficiency syndrome patientG Tachedjian, J Hoy, K McGavin, et al.Proceedings of the National Academy of Sciences of the United States of America|June 7, 2000
Analysis of mutations and suppressors affecting interactions between the subunits of the HIV type 1 reverse transcriptaseG Tachedjian, H E Aronson, S P GoffAIDS Research and Human Retroviruses|December 1, 1993
Cellular topoisomerase I activity associated with HIV-1D Jardine, G Tachedjian, S Locarnini, et al.AIDS Research and Human Retroviruses|August 26, 1998
Impaired fitness of foscarnet-resistant strains of human immunodeficiency virus type 1G Tachedjian, J W Mellors, H Bazmi, et al.Journal of Virology|October 1, 1996
Zidovudine resistance is suppressed by mutations conferring resistance of human immunodeficiency virus type 1 to foscarnetG Tachedjian, J Mellors, H Bazmi, et al.Journal of Viral Hepatitis|February 15, 2012
Identification of residues involved in NS2 homodimerization and elucidation of their impact on the HCV life cycleA A Gorzin, P A Ramsland, G Tachedjian, et al.Proceedings of the National Academy of Sciences of the United States of America|June 21, 2001
Nonnucleoside reverse transcriptase inhibitors are chemical enhancers of dimerization of the HIV type 1 reverse transcriptaseG Tachedjian, M Orlova, S G Sarafianos, et al.Pageof 2